Since January 1, 2022, a total of 96 countries in the world have reported monkeypox cases to WHO. As of August 22, 2022, there were 41,664 laboratory confirmed cases, 192 suspected cases and 12 dead cases. Most of the countries seriously affected by monkeypox epidemic in the world are distributed in North America and Europe, of which the United States has the largest number of cases, reaching 14049, accounting for 33.72% of the world.

Facing the rapidly spreading monkeypox epidemic in the world, Lumigenex have also worked hard to develop monkeypox virus nucleic acid detection kits,  IgG / IgM antibody rapid test kits and antigen rapid test kits, and These kits have obtained EU CE certification. The monkeypox virus antigen/antibody test kits (colloidal gold method) uses samples such as whole blood, serum and rash exudate. The operation is simple and fast, and the results can be obtained in 15 minutes. The specificity of the kit is as high as 99%! Monkeypox virus antigen/antibody test kit (colloidal gold method) can be stored at 4-30 ℃ without cold chain transportation, and is suitable for screening large-scale suspected monkeypox infected people. We welcome partners with overseas channels to discuss cooperation!